Skip to main content
High RiskFDAfda-F-0077-2023UNDECLARED ALLERGEN

Qassim Mix for Coffee, Net Weight 125g, packaged in a plastic container (UPC 6-281103 300011). Each case contains 48-125g containers.

Category
Units Affected
4
Recall Date
June 9, 2022
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0077-2023.

The product is labeled to contain sodium caseinate, a milk derivative, but the label does not declare the product contains "milk."

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0077-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Tomoorona Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0077-2023.

Tomoorona LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Tomoorona Llc Recall FAQ

Tomoorona Llc is the subject of a beverages safety report: Qassim Mix for Coffee, Net Weight 125g, packaged in a plastic container (UPC 6-281103 300011). Each case contains 48-125g containers.. The notice was published on June 9, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 4 units are potentially affected.